Selective Estrogen Receptor Modulators (SERMs) can be a cornerstone of pharmaceutical PCT interventions. They functionality as aggressive inhibitors at estrogen receptors from the hypothalamus when exhibiting tissue-selective agonist or antagonist Houses through the entire human body. SERMs are essential in regulating post cycle estrogen output and